Laure Croisille Selected Research

belimumab

1/2021

Efficacy, safety and immunological profile of combining rituximab with belimumab for adults with persistent or chronic immune thrombocytopenia: results from a prospective phase 2b trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laure Croisille Research Topics

Disease

4	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2021 - 02/2014
3	Neutropenia 01/2019 - 10/2014
2	Thrombocytopenia (Thrombopenia) 01/2019 - 02/2014
2	Neonatal Alloimmune Thrombocytopenia 01/2019 - 01/2016
2	Neoplasms (Cancer) 01/2019 - 05/2002
1	Reinfection 10/2021
1	Platelet Glycoprotein IV Deficiency 11/2020
1	Pure Red-Cell Aplasia 01/2019
1	Pancytopenia 01/2019
1	Infections 01/2019
1	Febrile Neutropenia 01/2019
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 01/2019
1	Aplastic Anemia (Anemia, Hypoplastic) 01/2019
1	Cytopenia 01/2019
1	Thrombophilia 04/2018
1	Atrial Fibrillation 04/2018
1	Thrombasthenia (Glanzmann Thrombasthenia) 04/2018
1	Stroke (Strokes) 04/2018
1	Ulcerative Colitis 10/2014
1	Agranulocytosis (Granulocytopenia) 10/2014
1	Hemorrhage 02/2014
1	Thalassemia 06/2005
1	Hereditary Elliptocytosis 06/2005
1	Hemangioblastoma 05/2002
1	Polycythemia (Erythrocytosis) 05/2002

Drug/Important Bio-Agent (IBA)

4	AntibodiesIBA 01/2019 - 02/2014
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2021 - 01/2019
2	Inosine Triphosphate (ITP)IBA 01/2021 - 02/2014
2	Human Platelet AntigensIBA 01/2019 - 01/2016
1	belimumabIBA 01/2021
1	Rituximab (Mabthera)FDA Link 01/2021
1	B-Cell Activating FactorIBA 01/2021
1	GuanineIBA 11/2020
1	Codon (Codons)IBA 11/2020
1	Methylprednisolone FDA LinkGeneric 01/2020
1	Glycoproteins (Glycoprotein)IBA 01/2019
1	Heme (Haem)IBA 01/2019
1	LigandsIBA 01/2019
1	Prothrombin (Factor II)IBA 04/2018
1	Vitamin K FDA Link 04/2018
1	human ITGB3 protein (HPA-1a)IBA 01/2016
1	Biological ProductsIBA 10/2014
1	AutoantibodiesIBA 10/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2014
1	Infliximab (Remicade)FDA Link 10/2014
1	AntigensIBA 02/2014
1	Monoclonal AntibodiesIBA 02/2014
1	Hemoglobins (Hemoglobin)IBA 06/2005
1	Hemoglobin Constant SpringIBA 06/2005
1	Semaxinib (SU5416)IBA 05/2002
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2002
1	Retinaldehyde (Retinal)IBA 05/2002
1	Angiogenesis InhibitorsIBA 05/2002
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 05/2002

Therapy/Procedure

5	Therapeutics 10/2021 - 05/2002
1	Antibiotic Prophylaxis 10/2021
1	Immunotherapy 01/2019
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 04/2018
1	Length of Stay 04/2018
1	Carotid Endarterectomy 04/2018